Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Amgen Hyderabad is seeking a Senior Scientist in Data Analytics and Pharmacometric Modeling to advance model-informed drug development. You will build PK/PD and quantitative systems pharmacology models using clinical and preclinical data to guide dose selection, study design, and development decisions.
The role emphasizes collaboration with CPMS, therapeutic area teams, and external partners to translate analyses into actionable insights and contribute to publications and regulatory submissions.
Join Amgen’s Clinical Pharmacology, Modeling and Simulation (CPMS) team as a Senior Scientist and help shape the future of drug development through data science, predictive analytics, pharmacometrics, and quantitative systems pharmacology. In this role, you will apply innovative modeling and simulation approaches to support critical decisions across clinical development programs and therapeutic areas. You will work in a collaborative, science-driven environment alongside CPMS colleagues, therapeutic area teams, external partners, and cross-functional R&D stakeholders. This is an opportunity to contribute to model-informed drug development, influence study design and dose selection, and help bring meaningful therapies to patients. The ideal candidate is a quantitative scientist who enjoys working with complex biological and clinical datasets, translating analyses into actionable insights, and communicating results clearly to multidisciplinary teams. You will have the opportunity to use established pharmacometric methods as well as emerging machine learning and AI-enabled tools to solve high-impact development questions.
The typical job responsibilities may include :
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen